Find an expert

Scott Beatson is an Associate Professor and NHMRC Career Development Fellow at The University of Queensland (UQ). He specializes in bacterial pathogenomics: using whole-genome sequencing to investigate transmission, pathogenesis and antibiotic resistance in bacteria. Recent work from his group includes genomic analyses of pandrug resistant enterobacteriaceae and the multidrug resistant Escherichia coli ST131 pandemic clone. He was awarded a PhD from UQ for his work in bacterial pathogenesis in 2002 and developed his career in bacterial genomics in the United Kingdom with the support of fellowships from the Royal Commission for the Exhibition of 1851 (University of Oxford) and the UK Medical Research Council (University of Birmingham). Since returning to Australia he has held fellowships from both the NHMRC and ARC and has led a successful research group in the School of Chemistry and Molecular Biosciences at UQ since 2008. He is also a member of the Australian Infectious Diseases Research Centre and the Australian Centre for Ecogenomics. In 2016 he received the Frank Fenner Award from the Australian Society for Microbiology in recognition of his contribution to microbiology research in Australia.

Gabrielle Belz originally trained in veterinary medicine and surgery and received her PhD in understanding the organisation of lymphatics and lymphoid tissues at The University of Queensland. After a short stint in Canada to work on B cells, she moved to St Jude Children’s Research Hospital to work with Peter Doherty supported by an NHMRC CJ Martin Fellowship. Here she established a number of systems that now allow tracking of virus-specific T cells and established the paradigm changing notion that CD4 T cell help was required for generating antiviral responses. She returned to The Walter and Eliza Hall Institute of Medical Research and uncovered the identity of the key dendritic cells necessary for initiating antiviral infections. Subsequently she was awarded the Burnet Prize and NHMRC Elizabeth Blackburn Fellowship. Her research contributions have been recognized by a number of awards including a Wellcome Trust Overseas Fellowship, HHMI international fellowship, ARC Future fellowship, Doctor of Veterinary Science, the Gottschalk Medal (Australian Academy of Science) and in 2024 an ARC Laureate Fellowship. Her laboratory focuses on deciphering the key cellular and transcriptional signals of protective immunity particularly by T cells and in understanding how innate immune cells develop and make novel contributions to mucosal immune defence.

Dr. Bialasiewicz worked at the Royal Children's Hospital and the Children's Health Queensland HHS for over 18 years conducting translational research and clinical support centering on infectious disease (primarily viral and bacterial) molecular diagnostics, general microbiology and molecular epidemiology. In 2019, he became a group leader at The University of Queensland's Australian Centre for Ecogenomics, expanding on a growing interest in the microbial ecology of the human body, it's role in health and disease, and ways to manipulated to achieve desirable outcomes. One Health microbial ecology, where human health is interconnected with the health of animals (both livestock and wildlife), and the broader environment is also an area of active interest. His background in virology has influenced the work he does, meaning a key focus of his microbial ecology works centres around the interactions between all types of microorgansims (bacteria, archaea, viruses, fungi, and micro-eukaryotes).

Ongoing work includes:

- Leveraging of emerging technologies to explore the hidden microbial diversity and their interactions in the human body.

- Using the technology to develop microbial (e.g. phage)-based treatments or preventatives to complex diseases (e.g. Otitis Media, Chronic Rhinosinusitis, GvHD).

- Understanding the genetics of antibiotic resistance spread.

Dr. Laura Grogan is a qualified veterinarian, Senior Lecturer in Wildlife Science, Chair of the Wildlife Disease Association Australasian section, and Leader of the Biodiversity Health Research Team (https://www.biodiversity-health.org/) - a collaborative multiple-university research group focused on finding sustainable solutions for the most challenging threatening processes currently affecting biodiversity.

Dr. Grogan has a background in research on wildlife diseases, ecology and conservation. She's particularly interested in investigating the dynamics, relative importance, and impacts of infectious diseases among other threats affecting wildlife across both individual and population scales, to improve conservation management. While she works across taxa and methodological approaches, her main study system currently involves the devastating amphibian fungal skin disease, chytridiomycosis, where at the individual scale she focuses on the pathogenesis and amphibian immune response to the disease, untangling the roles of resistance and tolerance in defense against infection. At the population and landscape scale she explores mechanisms underlying persistence in the face of endemic infection, focused on the endangered Fleay's barred frog. She also studies population and infection dynamics of chlamydiosis in koala using a mathematical modelling approach, exploring the relative benefits of different management approaches. In addition to working on amphibian and koala diseases, Laura is a keen birdwatcher, wildlife photographer and artist. She supervises projects across wildlife-related fields (predominantly vertebrates).

You can find out more about her research team here: www.biodiversity-health.org. Dr. Grogan has been awarded around $1.3 million in research funding since 2018. In late 2019 she was awarded an Australian Research Council Discovery Early Career Researcher Award (DECRA; DE200100490), worth $426,742. This project, titled "Understanding infection tolerance to improve management of wildlife disease", commenced in late 2020. Dr. Grogan was identified as one of the four top-ranked science DECRA awardees by the Australian Academy of Science’s 2020 J G Russell Award, and was also recipient of the highest award of the Wildlife Disease Association Australasia Section with their 2019 Barry L Munday Recognition Award.

PhD and Honours projects are now available in the following areas (plus many more areas - please get in touch if you have an idea):

• Can frogs be ‘vaccinated’ by antifungal treatment of active infections to develop protective immunity to the devastating chytrid fungus? (Principal Supervisor)
• Establishing the conservation status of south-east Queensland’s amphibians - occupancy surveys and species distribution models (Principal Supervisor)
• Tadpoles as a reservoir of the lethal frog chytrid fungal disease – measuring sublethal effects on growth, time to metamorphosis and ability to forage (mouthpart loss) (Principal Supervisor)
• Impacts of chytrid fungus on the survival of juvenile endangered Fleay’s barred frogs, Mixophyes fleayi, and importance for population recruitment (Principal Supervisor)
• Measuring the infection resistance versus tolerance of barred frogs to the devastating chytrid fungal disease to improve management outcomes (Principal Supervisor)
• Mapping the impacts of fire-fighting chemicals on endangered frog habitats (Co-Supervisor)
• Bowra birds: what do long-term monitoring data reveal about bird communities in the semi-arid region? (Co-Supervisor)
• Impacts of fire-fighting chemicals on endangered frogs: Implications for conservation and management (Co-Supervisor)

CURRENT POSITIONS

· Senior Staff Specialist (Public Health Medicine), Queensland Health

· Principal Research Fellow, Centre for Clinical Research - University of Queensland

RECENT POSITIONS

· General Practitioner, Indooroopilly General Practice

· Director, Queensland Centre for Intellectual and Developmental Disability (to January 2021)

· Senior Medical Officer, Mater Intellectual Disability and Autism Service (to November 2020)

· General Practitioner, Cornwall Street Medical Centre (to November 2020)

A/Prof Sumaira Hasnain graduated with her PhD in December 2010 from The University of Manchester and is an Associate Professor at Mater Research with a team of eight researchers. A/Prof Hasnain was the first globally to demonstrate that immunity can modulate protein production in secretory cells in infection and chronic diseases. Her long-term vision has been to characterise these novel immune factors and manipulate them therapeutically using pre-clinical models of immune-driven pathologies.

A/Prof Hasnain holds a patent for targeted immunotherapy in metabolic disease which has led to the formation of a spin-off company, Jetra Therapeutics and venture capitalist funding. She has a rapid upward trajectory in research, evident by extensive body of high-quality publications including in Nature Medicine, Nature Communications, Journal of Experimental Medicine, Oncogene and Gastroenterology. She has been awarded more than $9 million in competitive funding and recently gained the National Health and Medical Research Council L1 Investigator Grant. A/Prof Hasnain has won 21 awards to date, including the Commercialisation award from The University of Queensland in 2022 and the Gastroenterological Society for Australasia; Lawrie Powell Award in 2023.

Paul specialises in Assessment and Management of Risk and Impact of Socio-Environmental determinants on the Wellbeing of our younger generations across their life span.

His overall vision is about how we use Environmental Health Intelligence to improve decision-making towards delivering more efficient Environmental Health Practices, Services and Solutions for local and regional communities in remote and disadvantaged socio-economic settings.

Within the complex interdisciplinary domains that hold the socio-environmental determinants of wellbeing, Paul’s operational research focuses on how / what interventions would best support communities to prevent, mitigate and adapt to EH risk and impact in rapidly changing environments and climate.

Prof Tim Mahony joined QAAFI’s Centre for Animal Science in October 2010, after 15 years of conducting research projects with the Queensland Government. He obtained his PhD from James Cook University in the area of molecular microbiology. During 2001 and 2002, Prof Mahony was a visiting professor at the University of Saskatchewan.

Research interests

Dr Mahony’s research interests are in the area of molecular virology revolving around improving viral disease control in production animals such as cattle and poultry. His group is characterising the molecular interactions between invading pathogens and the subsequent host responses with the goal of developing new vaccines and diagnostic technologies. A key component of this work includes improving the basic understanding of the molecular mechanisms that underpin and drive viral virulence and evolution. Next-generation sequencing has been used to sequence the genomes of herpesviruses and adenoviruses from a variety of species including, cattle, chickens, marsupials, horses, and crocodiles. Prof Mahony’s team is also investigating the role of virally encoded microRNAs in virulence, replication, and disease development. His group was one of the first in the world to apply bacterial artificial chromosome infectious clone technology for the efficient manipulation of herpesviruses that have large DNA genomes. These strategies are also being exploited to understand viral gene function and the development of vaccines.

Currently, Prof Mahony is researching risk factors that protect and predispose feedlot cattle to developing bovine respiratory disease (BRD). He is also leading the development of new vaccines for BRD and cattle tick infestations. Prof Mahony has also led the development of new vaccine delivery technologies for the poultry industry targeting the application of in ovo strategies. Prof Mahony research into improving animal health is increasing industry productivity, food safety, and consumer confidence in food products and he is keen to explore collaborations with other scientists in this area.

Prof Mahony has a strong interest to work with post-graduate students and has supervised a number of post-graduate students from Australia and overseas. These projects have covered research areas in molecular virology, animal health, vaccine development, and pathogen-host interactions.

Karnaker's research interests are natural products, peptide-based drug discovery and development, formulation chemistry and non-viral gene delivery system. Karnaker co-inventor and developed a novel, bioresponsive disulphide-linker technology, which has been used for non-viral vectors, peptide-therapeutics for pain and cancer treatment. Karnaker is also keen interest for topical, mucosal drug delivery using a range of dendrimer, nano and microbubbles, lipid and polymer-based nanoparticle systems in conjugation with both biological and physical stimuli-responsiveness.

Karnaker received a PhD in Pharmaceutical Chemistry from The University Queensland under the supervision of Dr Harendra Parekh and Dr Defang Ouyang. Prior to PhD, he completed a Master degree in Pharmaceutical Analysis and Quality assurance (India). Also worked as analytical research and development chemist for one year in a Pharma company. Since 2016, he his working with Dr Parekh team on a range of Industry-funded research projects and his role involves from ideation, research plan, execution, product delivery to industry partners on major platforms such as peptide-based therapeutics, gene therapy and sol-gel technology.

I have a keen interest in the evolutionary relationships that underpin symbioses, particularly those involved in plant disease. There are countless examples of how diseases have impacted on different crops throughout history, and this is an ongoing issue that deleteriously impacts food security. My research involves developing a better understanding of the epidemiology of plant diseases and pests, and delivering improved diagnostics and field management. Working with collaborators and international experts, my work involves research on a broad range of plants that are affected by bacteria, fungi, oomycetes and viruses. I have a strong interest in the biotic factors that govern soil health and the methods by which we can promote the development of beneficial microbial communities.